SharonMannheimerMD(She/Her)
Infectious Disease • New York, NYHIV/AIDS Medicine, International Health, Travel & Tropical
Professor, Medicine, Columbia University College of Phys & Surg
Dr. Mannheimer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
506 Lenox Ave
Room 3101-A
New York, NY 10037Phone+1 212-939-2940Fax+1 212-939-2968
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Infectious Disease, 1992 - 1995
University of RochesterResidency, Internal Medicine, 1989 - 1992
Case Western Reserve University School of MedicineClass of 1989
Certifications & Licensure
NY State Medical License 1990 - 2025
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2010-2013
- Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2010-2013
Clinical Trials
- A Study of Two Adherence Plans to Help HIV-Positive Patients Take Their Medications Correctly
- PrEPared and Strong: Clinic-Based PrEP for Black MSM Start of enrollment: 2015 Mar 30
- Evaluating the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Combinations of Monoclonal Antibodies PGT121, PGDM1400, 10-1074, and VRC07-523LS Administered Via Intravenous Infusion in Healthy, HIV-uninfected Adult Participants Start of enrollment: 2019 Jul 17
Publications & Presentations
PubMed
- Pharmacokinetic interaction assessment of an HIV broadly neutralizing monoclonal antibody VRC07-523LS: a cross-protocol analysis of three phase 1 trials in people with...Tariro D Chawana, Stephen R Walsh, Lynda Stranix-Chibanda, Zvavahera M Chirenje, Chenchen Yu
BMC Immunology. 2025-02-19 - Cabotegravir Maintains Protective Efficacy in the Setting of Bacterial STIs: A Secondary Analysis of HPTN 083.Meredith E Clement, Brett Hanscom, Daniel Haines, Jose A Bazan, Nuntisa Chotirosniramit
Clinical Infectious Diseases. 2024-11-23 - 8 citationsSafety, tolerability, pharmacokinetics, and immunological activity of dual-combinations and triple-combinations of anti-HIV monoclonal antibodies PGT121, PGDM1400, 10-...Magdalena E Sobieszczyk, Sharon Mannheimer, Carmen A Paez, Chenchen Yu, Theresa Gamble
The Lancet. HIV. 2023-10-01
Press Mentions
ICAP Leads Community Effort to Fight COVID-19 in New York CityApril 6th, 2021
Research History
- Site Leader, Harlem Prevention Center Clinical Research SiteOversee clinical trials conducted through the HIV Prevention Trials Network (HPTN) and the COVID Prevention Network (CoVPN)
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
